Uniting research and manufacturing to help patients faster
The opening of our updated site in Ireland will increase collaboration and speed to market
October 5, 2023
Great science requires collaboration. At Merck, scientists and engineers from across the company work together to achieve our purpose of using the power of leading-edge science to save and improve lives.
And at our new state-of-the-art site in Dunboyne, Ireland, we’re bringing together our research and manufacturing teams for the first time to support stronger collaboration during the development and manufacturing of clinical supplies.
“At Dunboyne, we’ll see the power of teamwork between the teams, creating a model that becomes our new way of working,” said Sanat Chattopadhyay, executive vice president and president, Merck Manufacturing Division. “This site offers the chance to harness the expertise of our exceptional manufacturing and research teams.”
Two facilities, one team
The two components of our Dunboyne site will play a pivotal role in our biologics pipeline. Combined, they represent our first single-use commercialization facility dedicated to manufacturing key biologics for clinical trials, product registration and launch. At the nearby manufacturing facility, teams design the process engineering necessary to produce biologics at a large scale.
The close collaboration of these teams will significantly increase our speed to market and ultimately quicken our ability to help patients.
"This integrated approach will use state-of-the-art scientific and technological innovations to get our medicines to people around the world who need them the most, faster than ever before.”
— Mike Kress
Senior vice president, chemistry, Merck Research Laboratories
